PredictaBio

Curated by Signal

AI-driven synthetic biology platform for protein synthesis

Overview

AI-driven synthetic biology platform for protein synthesis. It transforms synthetic biology with advanced predictive analytics and unique biodiverse databases to generate novel and sustainable proteins, enhancing productivity and activity predictions.

Key facts

Founded: 2023
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Eargo
Provider of hearing aids for people with hearing disabilities
Life Sciences TechnologySan Jose, United States
Anatomotion
Developer of a wearable technology solution for dental care
Life Sciences TechnologyAustin, United States
Catalyst OrthoScience
A total shoulder implant solution
Life Sciences TechnologyNaples, United States

About PredictaBio

What does PredictaBio do?

AI-driven synthetic biology platform for protein synthesis.

Where is PredictaBio headquartered?

PredictaBio is headquartered in Boston, United States.

When was PredictaBio founded?

PredictaBio was founded in 2023.

Which sector is PredictaBio in?

PredictaBio operates in Life Sciences Technology.

Who are PredictaBio's competitors?

Companies similar to PredictaBio include Eargo, Anatomotion, and Catalyst OrthoScience.